title: The case for expanding access to highly active antiretroviral therapy to curb the growth of the HIV epidemic.
authors.affiliation: British Columbia Centre for Excellence in HIV/AIDS, Providence Health Care, University of British Columbia, Vancouver, Canada. jmontaner@cfenet.ubc.ca
authors.forename: Julio S G
authors.initials: JS
authors.lastname: Montaner
authors.forename: Robert
authors.initials: R
authors.lastname: Hogg
authors.forename: Evan
authors.initials: E
authors.lastname: Wood
authors.forename: Thomas
authors.initials: T
authors.lastname: Kerr
authors.forename: Mark
authors.initials: M
authors.lastname: Tyndall
authors.forename: Adrian R
authors.initials: AR
authors.lastname: Levy
authors.forename: P Richard
authors.initials: PR
authors.lastname: Harrigan
mesh_terms: D023241:Antiretroviral Therapy, Highly Active / Q000191:economics*; D003362:Cost-Benefit Analysis; D005260:Female; D014943:Global Health; D015658:HIV Infections / Q000188:drug therapy* / Q000453:epidemiology / Q000517:prevention & control; D006801:Humans; D015994:Incidence; D008297:Male